Article
Regulation of EGFR signalling by palmitoylation and its role in tumorigenesis.
Open biology - 1 Oct 2021
Kadry Yasmin A, Lee Jia-Ying, Witze Eric S
Abstract excerpt
The epidermal growth factor receptor (EGFR) is an essential driver of oncogenic signalling, and EGFR inhibitors are some of the earliest examples of successful targeted therapies in multiple types of cancer. The tractability of EGFR as a therapeutic target is overshadowed by the inevitable drug resistance that develops. Overcoming resistance mechanisms requires a deeper understanding of EGFR regulation in cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
